Ayub S, Parnia S, Poddar K, Bachu AK, Sullivan A, Khan AM, et al. Xylazine in the opioid epidemic: a systematic review of case reports and clinical implications. Cureus. 2023;15(3):e36864. https://doi.org/10.7759/cureus.36864.

Article  PubMed  PubMed Central  Google Scholar 

Greene SA, Thurmon JC. Xylazine: a review of its pharmacology and use in veterinary medicine. J Vet Pharmacol Ther. 1988;11(4):295–313. https://doi.org/10.1111/j.1365-2885.1988.tb00189.x.

Article  CAS  PubMed  Google Scholar 

Kyei EF, Kyei GK, Ansong R, Boakye CK, Asamoah E. Xylazine in the unregulated drug market: an integrative review of its prevalence, health impacts, and detection and intervention challenges in the United States. Policy Polit Nurs Pract. 2024;25(4):241–53. https://doi.org/10.1177/15271544241268386.

Article  PubMed  Google Scholar 

Ball NS, Knable BM, Relich TA, Smathers AN, Gionfriddo MR, Nemecek BD, et al. Xylazine poisoning: a systematic review. Clin Toxicol (Phila). 2022;60(8):892–901. https://doi.org/10.1080/15563650.2022.2063135.

Article  PubMed  Google Scholar 

Isa AK, Adeyemo I. Xylazine and fentanyl co-involvement in U.S. overdose deaths: a systematic review of public health trends, mechanisms, and intervention gaps. J Front Multidisciplinary Res. 2025;6(2):96–102. https://doi.org/10.54660/.JFMR.2025.6.2.96-102.

Article  Google Scholar 

Silva-Torres LA, Velez C, Lyvia Alvarez J, Ortiz JG, Zayas B. Toxic effects of xylazine on endothelial cells in combination with cocaine and 6-monoacetylmorphine. Toxicol Vitro. 2014;28(7):1312–9. https://doi.org/10.1016/j.tiv.2014.06.013.

Article  CAS  Google Scholar 

Carruthers SG, Nelson M, Wexler HR, Stiller CR. Xylazine hydrochloridine (Rompun) overdose in man. Clin Toxicol. 1979;15(3):281–5. https://doi.org/10.3109/15563657908989878.

Article  CAS  PubMed  Google Scholar 

Spoerke DG, Hall AH, Grimes MJ, Honea BN 3rd, Rumack BH. Human overdose with the veterinary tranquilizer xylazine. Am J Emerg Med. 1986;4(3):222–4. https://doi.org/10.1016/0735-6757(86)90070-7.

Article  CAS  PubMed  Google Scholar 

Hoffmann U, Meister CM, Golle K, Zschiesche M. Severe intoxication with the veterinary tranquilizer xylazine in humans. J Anal Toxicol. 2001;25(4):245–9. https://doi.org/10.1093/jat/25.4.245.

Article  CAS  PubMed  Google Scholar 

Johnson J, Pizzicato L, Johnson C, Viner K. Increasing presence of xylazine in heroin and/or fentanyl deaths, Philadelphia, Pennsylvania, 2010–2019. Inj Prev. 2021;27(4):395–8. https://doi.org/10.1136/injuryprev-2020-043968.

Article  PubMed  Google Scholar 

Korn WR, Stone MD, Haviland KL, Toohey JM, Stickle DF. High prevalence of xylazine among fentanyl screen-positive urines from hospitalized patients, Philadelphia, 2021. Clin Chim Acta. 2021;521:151–4. https://doi.org/10.1016/j.cca.2021.07.010.

Article  CAS  PubMed  Google Scholar 

Sibbesen J, Abate MA, Dai Z, Smith GS, Lundstrom E, Kraner JC, et al. Characteristics of xylazine-related deaths in West Virginia. Am J Addict. 2023;32(3):309–13. https://doi.org/10.1111/ajad.13365.

Article  PubMed  Google Scholar 

Cano M, Daniulaityte R, Marsiglia F. Xylazine in overdose deaths and forensic drug reports in US states, 2019–2022. JAMA Netw Open. 2024;7(1):e2350630. https://doi.org/10.1001/jamanetworkopen.2023.50630.

Article  PubMed  PubMed Central  Google Scholar 

Potoukian RB, Gonyea J, Shoff EN, Hime GW, Moore DM. Prevalence of xylazine in overdose cases: an analysis of Miami-Dade County medical examiner case data. J Forensic Sci. 2023;68(6):2205–10. https://doi.org/10.1111/1556-4029.15375.

Article  PubMed  Google Scholar 

Jones S, Bailey S. Xylazine test strips for drug checking. Can J Health Technol. 2023;3(7):1–13. https://doi.org/10.51731/cjht.2023.691

Troike KM, McShane AJ. Detecting xylazine: prevalence, pharmacokinetics, and analytical considerations. Clin Lab Med. 2025;45(2):283–94. https://doi.org/10.1016/j.cll.2025.01.011.

Article  PubMed  Google Scholar 

Keary CJ, Wang Y, Moran JR, Zayas LV, Stern TA. Toxicologic testing for opiates: understanding false-positive and false-negative test results. Prim Care Companion CNS Disord. 2012;14(4):12–7. https://doi.org/10.4088/PCC.12f01371.

Article  Google Scholar 

Johnson-Davis KL, Saker SJ, Hubbard JA. Modern drug testing in clinical laboratories: a narrative review of practical approaches and emerging technologies. J Lab Precis Med. 2025;10:22. https://doi.org/10.21037/jlpm-25-23.

Article  Google Scholar 

Malaca S, Pesaresi M, Kapoor A, Berretta P, Busardò FP, Pirani F. Pharmacology and toxicology of xylazine: quid novum? Eur Rev Med Pharmacol Sci. 2023;27(15):7337–45. https://doi.org/10.26355/eurrev_202308_33305.

Article  CAS  PubMed  Google Scholar 

Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372:n160. https://doi.org/10.1136/bmj.n160.

Article  PubMed  PubMed Central  Google Scholar 

National Heart, Lung, and Blood Institute. Study quality assessment tools: quality assessment tool for observational cohort and cross-sectional studies. National Heart, Lung, and Blood Institute, National Institutes of Health. 2021. Accessed 3 Jan 2026. https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools

Alexander R, Agwuncha C, Wilson C, Schrecker J, Holt A, Heltsley R. Withdrawal signs and symptoms among patients positive for fentanyl with and without xylazine. J Addict Med. 2025;19(2):202–7. https://doi.org/10.1097/ADM.0000000000001423.

Article  CAS  PubMed  Google Scholar 

Mantych M, Laibly C, Russell H, Beyer KMM, Zhou Y, Anguzu R. Epidemiology of xylazine-positive fatal overdoses in Milwaukee County, Wisconsin, 2019–2023. WMJ. 2025;124(2):148–52.

PubMed  Google Scholar 

Thakrar AP, Zwiebel SJ, Christine PJ, Spadaro A, Davis MH, Bhatia R, et al. Manifestations of potential xylazine withdrawal: a retrospective cohort study with nested case series. Drug Alcohol Depend. 2025;272:112681. https://doi.org/10.1016/j.drugalcdep.2025.112681.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang EY, Phipps R, Dean SA, Li L, Nestadt D, Nestadt PS. Characterization of xylazine-related overdose deaths in Maryland (2020–2023). Drug Alcohol Depend. 2025;268:112553. https://doi.org/10.1016/j.drugalcdep.2025.112553.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Young BL, Gqamana PP, Qiu Y, Nacca NE, Zhang YV. The prevalence of xylazine in patient urine samples that were positive for fentanyl in Western New York. J Appl Lab Med. 2025;10(3):572–82. https://doi.org/10.1093/jalm/jfae158.

Article  CAS  PubMed  Google Scholar 

Bradford W, Figgatt M, Scott KS, Marshall S, Eaton EF, Dye DW. Xylazine co-occurrence with illicit fentanyl is a growing threat in the Deep South: a retrospective study of decedent data. Harm Reduct J. 2024;21:46. https://doi.org/10.1186/s12954-024-00959-2.

Article  PubMed  PubMed Central  Google Scholar 

Dunn J, Schifano F, Dudley E, Guirguis A. Exploring human misuse and abuse of veterinary drugs: a descriptive pharmacovigilance analysis utilising the Food and Drug Administration’s Adverse Events Reporting System (FAERS). Toxics. 2024;12(11):777. https://doi.org/10.3390/toxics12110777.

Article  CAS  PubMed  PubMed Central  Google Scholar 

German D, Genberg B, Sugarman O, Saloner B, Sawyer A, Glick JL, et al. Reported xylazine exposure highly associated with overdose outcomes in a rapid community assessment among people who inject drugs in Baltimore. Harm Reduct J. 2024;21:18. https://doi.org/10.1186/s12954-024-00940-z.

Article  PubMed  PubMed Central  Google Scholar 

Hays HL, Spiller HA, DeRienz RT, Rine NI, Guo HT, Seidenfeld M, et al. Evaluation of the relationship of xylazine and fentanyl blood concentrations among fentanyl-associated fatalities. Clin Toxicol (Phila). 2024;62(1):26–31. https://doi.org/10.1080/15563650.2024.2309326.

Article  CAS  PubMed  Google Scholar 

London K, Li Y, Kahoud JL, Cho D, Mulholland J, Roque S, et al. Tranq dope: characterization of an ED cohort treated with a novel opioid withdrawal protocol in the era of fentanyl/xylazine. Am J Emerg Med. 2024;85:130–9.